PhaseBio Pharmaceuticals, Inc. (PHAS)
Operating Expenses
-$13.05M
TTM · Period ending: · USD
PHAS Operating Expenses
Latest reported-$13.05Mperiod ending
Latest reported-$13.05Mperiod ending
PHAS TTM Operating Expenses ($11.33M → -$13.05M)
TTM operating expenses
High-resolution chart · PNG
PHAS operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| -13,054,807 | |
| -7,183,807 | |
| 118,193 | |
| 111,927,000 | |
| 103,508,000 | |
| 96,215,000 | |
| 85,176,000 | |
| 71,242,000 | |
| 62,581,000 | |
| 48,668,000 | |
| 42,097,000 | |
| 37,970,000 | |
| 31,549,000 | |
| 25,471,000 | |
| 20,312,000 | |
| 14,846,000 | |
| 11,331,000 |